These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1484744

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S, Tebbs SE, Elliott TS.
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [Abstract] [Full Text] [Related]

  • 27. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
    Babalola CP, Patel KB, Nightingale CH, Nicolau DP.
    Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
    Kucukates E, Nalan Karayel E, Gultekin N, Okuyan E, Kansiz E, Gurler N.
    Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
    [No Abstract] [Full Text] [Related]

  • 29. In-vitro selection of resistance to vancomycin and teicoplanin in Enterococcus faecium and Enterococcus faecalis compared with Staphylococcus epidermidis.
    Markopulos E, Graninger W, Georgopoulos A.
    J Antimicrob Chemother; 1998 Jan; 41(1):43-7. PubMed ID: 9511036
    [Abstract] [Full Text] [Related]

  • 30. [Teicoplanin and vancomycin susceptibility in Staphylococcus aureus and coagulase-negative staphylococci].
    Caiaffa Filho HH, Lima Mde P, Sinto SI, Andriolo A, Mendes CM.
    Rev Assoc Med Bras (1992); 1994 Jan; 40(2):77-80. PubMed ID: 7820154
    [Abstract] [Full Text] [Related]

  • 31. [Study of the susceptibility of Staphylococcus sp. and Enterococcus sp. to teicoplanin and vancomycin].
    Mimica I, Mendes CM, Mimica L, Oplustil C, Pignatari AC, Sader H.
    Rev Assoc Med Bras (1992); 1996 Jan; 42(3):147-50. PubMed ID: 9138356
    [Abstract] [Full Text] [Related]

  • 32. Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.
    Knudsen JD, Fuursted K, Raber S, Espersen F, Frimodt-Moller N.
    Antimicrob Agents Chemother; 2000 May; 44(5):1247-54. PubMed ID: 10770759
    [Abstract] [Full Text] [Related]

  • 33. [Streptogramins and glycopeptides].
    Tsuji A.
    Nihon Rinsho; 2007 Feb 28; 65 Suppl 2 Pt. 1():360-6. PubMed ID: 17455646
    [No Abstract] [Full Text] [Related]

  • 34. In vitro activity of the new glycopeptide decaplanin.
    Neu HC, Chin NX, Niu WW.
    Eur J Clin Microbiol Infect Dis; 1992 May 28; 11(5):458-62. PubMed ID: 1330562
    [Abstract] [Full Text] [Related]

  • 35. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
    Tuazon CU, Miller H.
    Antimicrob Agents Chemother; 1984 Apr 28; 25(4):411-2. PubMed ID: 6233934
    [Abstract] [Full Text] [Related]

  • 36. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
    Odenholt I, Löwdin E, Cars O.
    Clin Microbiol Infect; 2003 Sep 28; 9(9):930-7. PubMed ID: 14616681
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1982 Oct 28; 1(5):278-81. PubMed ID: 6223812
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA, Jin YF, Ashby JP, Andrews JM, Wise R.
    J Antimicrob Chemother; 1990 Aug 28; 26(2):203-7. PubMed ID: 2145256
    [Abstract] [Full Text] [Related]

  • 40. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT, Dulworth JK, Brackman MA.
    Diagn Microbiol Infect Dis; 1991 Aug 28; 14(1):29-31. PubMed ID: 1826479
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.